Connexon Creative and Advanced Cell & Gene Therapy Launch Directory for the Cell and Gene Therapy Community
The Cell Therapy Pages fills an unmet need for a comprehensive and up-to-date directory of cell and gene therapy organizations.
Vancouver, Canada (PRWEB) June 2, 2008 -- Connexon Creative Inc. (Connexon), a company specializing in scientific and medical communications, and Advanced Cell & Gene Therapy, a consulting firm serving biotechnology companies and clinical laboratories, are pleased to announce the launch of The Cell Therapy Pages, a comprehensive directory of the cell and gene therapy community.
The Cell Therapy Pages is a searchable online database of over 1,800 organizations involved in cell therapy, gene therapy, cell-based immunotherapy, tissue engineering and regenerative medicine worldwide.
"The Cell Therapy Pages includes a unique classification scheme for industry and academic organizations, based on the type of products or services they provide or therapeutics they develop," said Tiffany Chiu, Connexon's Director Operations & Business Development. "This classification system allows users to quickly find the information they need and connect with potential customers and suppliers."
Members of the cell and gene therapy community can also submit and update their organizations' listings and purchase subscriptions through the interactive website at www.celltherapypages.com.
"The Cell Therapy Pages has been designed for the cell and gene therapy community, by people working in cell and gene therapy," commented Dr. Scott Burger, Principal of Advanced Cell & Gene Therapy. "This resource will enable more effective development of these novel products by providing readily accessible information about companies developing cell- and gene-based therapeutics, sources of key products and services and academic investigators."
The Cell Therapy Pages has been endorsed by the International Society for Cellular Therapy, as a publication that "is consistent with the standards of the International Society for Cellular Therapy (ISCT) and will support the development of the fields of cellular therapy, gene therapy, immunotherapy, tissue engineering and RNA interference."
Visit www.celltherapypages.com for additional information about the Cell Therapy Pages, including details on how to obtain a subscription, purchase advertising or submit/edit your organizations' listing.
Contact:
Tiffany Chiu
Director of Operations & Business Development
Connexon Creative Inc.
604.630.5515
tchiu@connexoncreative.com
About Connexon Creative Inc.
Connexon Creative is a Vancouver-based company that creates opportunities for scientific and medical collaboration by providing information, products and services that enhance communication. Connexon Creative also publishes Cell Therapy News, a free, weekly e-newsletter and website portal dedicated to providing the latest information affecting cellular therapies. For more information about Connexon Creative, visit www.connexoncreative.com.
About Advanced Cell & Gene Therapy
Advanced Cell & Gene Therapy is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. Advanced Cell & Gene Therapy provides practical, experienced guidance in development, GMP/GTP manufacturing, and regulatory compliance, as well as comprehensive scientific and technical strategic analysis of business opportunities in cell therapy, gene therapy and tissue therapies. For more information about Advanced Cell & Gene Therapy, visit www.ac-gt.com.
Cell Therapy Pages Premier Sponsors
Cell Therapy Pages would like to acknowledge the following premier sponsors:
Diamond:
STEMCELL Technologies Inc.
Silver:
STEMSOFT Software Inc.
Progenitor Cell Therapy, LLC.
MaxCyte Inc.
Bronze:
HemoGenix Inc.
ISCT Disclaimer:
The information included in the Cell Therapy Pages cannot substitute for the advice or direction of a health care professional or consultant, and ISCT makes no guarantees, nor can it assume any legal liability for the accuracy, completeness, or usefulness of such information or for any damage incurred directly or indirectly from the information. Reference to any specific product and/or organization within the directory does not imply its endorsement, recommendation or preference by ISCT.
# # #
|
